Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market
04:48am, Monday, 28'th Apr 2025
Getting dizzy from the stock market's gyrations? Join the club.
Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts
06:55pm, Thursday, 24'th Apr 2025
Vertex Pharmaceuticals (VRTX) closed at $492.47 in the latest trading session, marking a +0.01% move from the prior day.
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Wednesday, 23'rd Apr 2025
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
05:37pm, Tuesday, 22'nd Apr 2025
Vertex Pharmaceuticals (VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech's shares closed the day nearly 3% higher in price, on the back of two positive mentions by analysts tracking t
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Tuesday, 22'nd Apr 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold
09:53am, Tuesday, 22'nd Apr 2025
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However, you don't necessarily have to sacrifice growth for safety.
Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right
04:47am, Tuesday, 22'nd Apr 2025
President Trump isn't a fan of Fed Chairman Jerome Powell, despite nominating Powell to replace Janet Yellen in 2017. Trump recently called Powell a "major loser" on a social media post and demanded t
Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely
01:58pm, Monday, 21'st Apr 2025
Vertex Pharmaceuticals Inc VRTX is entering earnings week with some serious anticipation — and a bit of heartburn. The stock had a solid run in 2025, up nearly 20% year-to-date and 21% over the past
Analysts Say 12 Stocks Will Profit Most From Trump's Reign
08:00am, Monday, 21'st Apr 2025
First-quarter earnings season is in full swing. But investors playing the long game want to know which S&P 500 companies will profit most.
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
06:30am, Friday, 18'th Apr 2025
Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs
Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce
04:45am, Tuesday, 15'th Apr 2025
Yo-yos are fun for kids. But yo-yo stock markets aren't so fun for grown-up investors.
Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades
04:48am, Saturday, 12'th Apr 2025
"May you live in interesting times."
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner Internati
GreensKeeper Q1 2025 Portfolio Update
08:55am, Thursday, 10'th Apr 2025
Berkshire Hathaway led Q1 with a 17.5% return, driven by strong operating earnings and potential for significant acquisitions with over $300 billion in cash. Vertex Pharmaceuticals gained 20.4%, fuele
Contrary to what you might read on social media, Warren Buffett isn't a fan of tariffs. Berkshire Hathaway even recently took the unusual step of issuing a press release refuting social media claims t
